← Leaderboards
David B Agus
University Of California Los Angeles
$6,707,253
Attributed
$8,231,056
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–16$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$14,663,976 · 6
By mechanism
P50$7,600,170 · 3
U54$4,778,101 · 2
R01$2,285,705 · 1
Top collaborators
- Anthony Atala4 shared
- Shay Soker4 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Sanjiv S Gambhir$44,452,033
- Lily Wu$3,586,954
- Ralf Landgraf$4,127,423
- Enrico Stefani$14,005,717
- Steven G Potkin$29,404,842
Others in their field
Top investigators on “Research Study”
- David Heimbrook · Leidos Biomedical Research, Inc.$876,439,260
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$605,922,209
- Lawrence Corey · Fred Hutchinson Cancer Center$605,141,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$512,975,910
Research focus
Research StudyResearch PersonnelMonitorComplexImageLifeMolecularCancer PatientInterestReportingInstitutionProgramsAreaLiverNeoplasm MetastasisMalignant Neoplasm Of ProstateNeoplastic CellOrganGrowthBlood VesselsAntibodiesInhibitor/AntagonistDatabasesDisease Progression
Grant awards (23)
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$560,735
R01 · FY2016 · CA · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$577,096
R01 · FY2015 · CA · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$557,736
R01 · FY2014 · CA · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$590,138
R01 · FY2013 · CA · contact PI
Administrative Unit$4,624
U54 · FY2013 · CA · contact PI
Administrative Unit$4,817
U54 · FY2012 · CA · contact PI
Lymphagiogenesis and Lymphatic Metastasis in Prostate Cancer$227,228
P50 · FY2011 · CA · contact PI
Administrative Unit$4,802
U54 · FY2011 · CA · contact PI
Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer$1,088,432
U54 · FY2010 · CA · contact PI
Lymphagiogenesis and Lymphatic Metastasis in Prostate Cancer$239,188
P50 · FY2010 · CA · contact PI
Administrative Unit$4,967
U54 · FY2010 · CA · contact PI
Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer$1,047,738
U54 · FY2009 · CA · contact PI
Lymphagiogenesis and Lymphatic Metastasis in Prostate Cancer$239,137
P50 · FY2009 · CA · contact PI
Administrative Unit$500
U54 · FY2009 · CA · contact PI
Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer$990,371
U54 · FY2008 · CA · contact PI
Lymphagiogenesis and Lymphatic Metastasis in Prostate Cancer$239,099
P50 · FY2008 · CA · contact PI
Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer$972,978
U54 · FY2007 · CA · contact PI
Lymphagiogenesis and Lymphatic Metastasis in Prostate Cancer$222,598
P50 · FY2007 · CA · contact PI
Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer$658,872
U54 · FY2006 · CA · contact PI
UCLA SPORE IN PROSTATE CANCER$2,272,341
P50 · FY2004 · CA
UCLA SPORE IN PROSTATE CANCER$2,272,378
P50 · FY2003 · CA
UCLA SPORE IN PROSTATE CANCER$1,888,201
P50 · FY2002 · CA
Independence in Human Prostate Cancer$0
P50 · FY2002 · CA